Equities research analysts expect that NutriSystem Inc. (NASDAQ:NTRI) will announce $0.61 earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NutriSystem’s earnings. The highest EPS estimate is $0.62 and the lowest is $0.61. NutriSystem posted earnings of $0.42 per share during the same quarter last year, which indicates a positive year over year growth rate of 45.2%. The business is expected to report its next quarterly earnings results on Monday, February 25th.
According to Zacks, analysts expect that NutriSystem will report full year earnings of $2.12 per share for the current financial year, with EPS estimates ranging from $2.11 to $2.13. For the next year, analysts anticipate that the firm will post earnings of $2.42 per share, with EPS estimates ranging from $2.34 to $2.47. Zacks’ earnings per share averages are a mean average based on a survey of analysts that follow NutriSystem.
NutriSystem (NASDAQ:NTRI) last issued its quarterly earnings results on Tuesday, October 30th. The company reported $0.54 EPS for the quarter, hitting analysts’ consensus estimates of $0.54. The company had revenue of $159.30 million during the quarter, compared to analyst estimates of $164.18 million. NutriSystem had a return on equity of 43.46% and a net margin of 8.06%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.49 earnings per share.
Several analysts have recently commented on NTRI shares. ValuEngine upgraded NutriSystem from a “hold” rating to a “buy” rating in a report on Friday, December 21st. Barrington Research reissued a “hold” rating on shares of NutriSystem in a research note on Monday, October 22nd. BidaskClub raised NutriSystem from a “sell” rating to a “hold” rating in a research note on Saturday, October 13th. Craig Hallum lowered NutriSystem from a “buy” rating to a “hold” rating and set a $45.00 price target on the stock. in a research report on Monday, December 10th. Finally, Zacks Investment Research raised NutriSystem from a “sell” rating to a “hold” rating in a research report on Tuesday, November 6th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $43.71.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ceredex Value Advisors LLC bought a new stake in shares of NutriSystem during the 3rd quarter valued at about $27,746,000. Eagle Asset Management Inc. grew its holdings in NutriSystem by 28.6% during the third quarter. Eagle Asset Management Inc. now owns 2,727,430 shares of the company’s stock valued at $101,051,000 after purchasing an additional 606,301 shares during the period. Man Group plc grew its holdings in NutriSystem by 89.7% during the third quarter. Man Group plc now owns 610,100 shares of the company’s stock valued at $22,605,000 after purchasing an additional 288,513 shares during the period. Penn Capital Management Co. Inc. bought a new position in NutriSystem during the third quarter valued at $10,947,000. Finally, BlackRock Inc. boosted its holdings in shares of NutriSystem by 6.7% in the second quarter. BlackRock Inc. now owns 4,346,504 shares of the company’s stock worth $167,340,000 after acquiring an additional 274,721 shares during the period.
Shares of NASDAQ NTRI traded down $0.14 during trading hours on Friday, reaching $43.54. The stock had a trading volume of 641,375 shares, compared to its average volume of 1,180,648. NutriSystem has a twelve month low of $26.06 and a twelve month high of $49.30. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of 22.21, a PEG ratio of 1.44 and a beta of 0.67.
NutriSystem announced that its board has approved a share repurchase plan on Tuesday, October 30th that authorizes the company to repurchase $75.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 7.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.
NutriSystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
Featured Article: Index Funds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.